Cargando…

Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer to transform effectively EMVI and MRF from positive to negative: results of a long-term single center phase 2 clinical trial

PURPOSE: Chemoradiotherapy (CRT) remains the standard treatment for locally advanced rectal cancer (LARC). This phase 2 clinical trial was designed to evaluate the efficacy and safety of neoadjuvant triplet chemotherapy with mFOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin, and irinotecan) in L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wen, Zhou, Haitao, Jiang, Jun, Zhu, Yuelu, Zou, Shuangmei, Jiang, Liming, Tang, Yuan, Liang, Jianwei, Sun, Yongkun, Jiang, Zhichao, Qu, Wang, Li, Ying, Zhou, Aiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294487/ https://www.ncbi.nlm.nih.gov/pubmed/37370032 http://dx.doi.org/10.1186/s12885-023-11103-x

Ejemplares similares

Prognostic Significance of EMVI in Rectal Cancer in a Tertiary Cancer Hospital in India
por: Pangarkar, Sayali Y., et al.
Publicado: (2021)

A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases
por: Siddiqui, Muhammed R S, et al.
Publicado: (2017)

Aeropuerto nacional de Xalapa - EMVI
por: Benitez López, Víctor Hugo
Publicado: (2021)

Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China
por: Zhu, Yuelu, et al.
Publicado: (2017)

Development of basic building blocks for cryo-EM: the emcore and emvis software libraries
por: de la Rosa-Trevín, José Miguel, et al.
Publicado: (2020)

Comparison of S‐1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (XELOX) as adjuvant chemotherapies for stage II and III gastric cancer after D2 resection: A single‐center retrospective study
por: Jiang, Zhichao, et al.
Publicado: (2020)

Biweekly oxaliplatin plus S1 for Chinese elderly patients with advanced gastric or gastroesophageal junction cancer as the first-line therapy: a single-arm, phase 2 study
por: Jiang, Zhichao, et al.
Publicado: (2022)

Case report: potential treatment of metastatic amphicrine carcinoma of the rectum with FOLFOXIRI chemotherapy
por: Tamura, Nobumasa, et al.
Publicado: (2020)

Nab-paclitaxel plus tegafur gimeracil oteracil potassium capsule (S-1) as first-line treatment for advanced biliary tract adenocarcinoma: a phase 2 clinical trial
por: Zhang, Wen, et al.
Publicado: (2021)

Encouraging Pathological Complete Response Rate from Neoadjuvant Chemotherapy with Albumin-Bound Paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Esophageal Squamous Carcinoma: Preliminary Outcome of a Retrospective Study
por: Zhang, Wen, et al.
Publicado: (2021)

MRI texture analysis in predicting treatment response to neoadjuvant chemoradiotherapy in rectal cancer
por: Meng, Yankai, et al.
Publicado: (2017)

A pilot phase II study of neoadjuvant triplet chemotherapy regimen in patients with locally advanced resectable colon cancer
por: Zhou, Haitao, et al.
Publicado: (2016)

Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy
por: Zhou, Sicheng, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
por: Papaccio, Federica, et al.
Publicado: (2020)

Cardiac MRF using rosette trajectories for simultaneous myocardial T(1), T(2), and proton density fat fraction mapping
por: Liu, Yuchi, et al.
Publicado: (2022)

MRI Evaluation of Extramural Venous Invasion (EMVI) with Rectal Carcinoma Using High Resolution T2 and Combination of High Resolution T2 and Contrast Enhanced T1 Weighted Imaging
por: Sofic, Amela, et al.
Publicado: (2021)

Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk (“ugly”) locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)
por: van den Berg, K., et al.
Publicado: (2022)

MRF-IUNet: A Multiresolution Fusion Brain Tumor Segmentation Network Based on Improved Inception U-Net
por: Jiang, Yongchao, et al.
Publicado: (2022)

Prognostic factors associated with locally advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by surgical resection
por: Sun, Yongkun, et al.
Publicado: (2017)

Correlation between Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Extramural Vascular Invasion (EMVI) in Locally Advanced Rectal Cancer
por: Gawiński, Cieszymierz, et al.
Publicado: (2022)

Effect of Time and Frequency of Magnetic Field Application on MRF Pressure Performance
por: Widodo, Purwadi Joko, et al.
Publicado: (2022)

Efficacy and Toxicity of Folfoxiri for Patients with Metastatic Colorectal Cancer
por: Huy, Trinh Le, et al.
Publicado: (2019)

Resolving the tissue response to neoadjuvant chemotherapy in rectal cancer
por: Shyer, Justin A., et al.
Publicado: (2023)

Risk factors and prognostic significance of lateral pelvic lymph node dissection after neoadjuvant chemoradiotherapy for rectal patients with clinically suspected lateral lymph node metastasis
por: Zhou, Sicheng, et al.
Publicado: (2021)

Log odds of positive lymph nodes is an excellent prognostic factor for patients with rectal cancer after neoadjuvant chemoradiotherapy
por: Xu, Tianlei, et al.
Publicado: (2021)

Quantitative Dynamic-Enhanced MRI and Intravoxel Incoherent Motion Diffusion−Weighted Imaging for Prediction of the Pathological Response to Neoadjuvant Chemotherapy and the Prognosis in Locally Advanced Gastric Cancer
por: Zhu, Yongjian, et al.
Publicado: (2022)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Lin, Huaqin, et al.
Publicado: (2021)

Improved Convolutive and Under-Determined Blind Audio Source Separation with MRF Smoothing
por: Zdunek, Rafał
Publicado: (2012)

FOLFOXIRI Resistance Induction and Characterization in Human Colorectal Cancer Cells
por: Ramzy, George M., et al.
Publicado: (2022)

Pathological complete response after neoadjuvant immunotherapy combined with chemotherapy in pediatric rectal carcinoma: A case report
por: Cao, Xiaomeng, et al.
Publicado: (2022)

FOLFOXIRI vs FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort study
por: Vienot, Angélique, et al.
Publicado: (2020)

Dual Contrast - Magnetic Resonance Fingerprinting (DC-MRF): A Platform for Simultaneous Quantification of Multiple MRI Contrast Agents
por: Anderson, Christian E., et al.
Publicado: (2017)

Accelerated magnetic resonance fingerprinting using soft-weighted key-hole (MRF-SOHO)
por: Cruz, Gastao, et al.
Publicado: (2018)

Feasibility study of 2D Dixon-Magnetic Resonance Fingerprinting (MRF) of breast cancer
por: Zanderigo, Eloisa, et al.
Publicado: (2022)

Predicting the response to neoadjuvant chemotherapy for breast cancer: wavelet transforming radiomics in MRI
por: Zhou, Jiali, et al.
Publicado: (2020)

Prognostic value of CEA and CA19-9 in patients with local advanced rectal cancer receiving neoadjuvant chemoradiotherapy, radical surgery and postoperative chemotherapy
por: Shan, Jingjing, et al.
Publicado: (2021)

Post-operative anastomotic leakage and collagen changes in patients with rectal cancer undergoing neoadjuvant chemotherapy vs chemoradiotherapy
por: Jiang, Wei, et al.
Publicado: (2022)

FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?
por: Lamarca, Angela, et al.
Publicado: (2020)

Total Neoadjuvant Chemotherapy in Rectal Cancer: Current Facts and Future Strategies
por: Beppu, Naohito, et al.
Publicado: (2023)

Anlotinib in the treatment of advanced hepatocellular carcinoma: an open-label phase II study (ALTER-0802 study)
por: Sun, Yongkun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hl6jenfkhphhkk6hdioa8p4bse